Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | INTS7 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
mRNA | IL2RB | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
mRNA | GABRA1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
mRNA | ZNF460 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
mRNA | FBXL13 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
mRNA | LRRK1 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
mRNA | DKK4 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
mRNA | POLD4 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
mRNA | GRN | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
mRNA | NCR1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |